The Traderszone Network

Published in TZ Latest News 10 December, 2021 by The TZ Newswire Staff

GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease confirms that the Company’s Director of Clinical Affairs & Medical Education, Erika Spaeth, PhD will be presenting at 2021 San Antonio Breast Cancer Symposium.